The investigated markers—CK20, CK5/6, and CD44—were altered in 65 (51.2%), 14 (11%), and 71 (55.9%) UTUC, respectively (Figure 1). This evidence concerns the gene CD44 and renal pelvis/ureter urothelial carcinoma.